Periodontal disease is multifactorial and in the last few years periodontal therapy has undergone a radical change from surgery to the development of gene targeted therapy. Clinical decision making, consequently at times becomes confusing and there is need today to look at individual variability in genes, environment and lifestyle before we treat the patient.

The biologic mechanisms which result in alveolar bone loss have been well investigated but they are unique to each individual patient. Evidence based decision making (EBDM) is based on statistical and or epidemiological data generally gathered through systematic meta-reviews of randomized clinical trials. Personalized periodontal therapy, on the other hand is based a better understanding of health and disease attributes unique to each individual. Though both approaches are systemically sound, at times we struggle to incorporate EBDM approaches because of the knowledge we have gained from our vast clinical experience.

So can we integrate evidence into clinical practice to move towards a better understanding of personalized periodontal therapy? Such an understanding requires a broader knowledge, a better compatibility of these two alternate ways, an ability to weigh both practical and theoretical considerations and ultimately a case-based reasoning rather than a population-based approach in order to arrive at the best treatment for an individual patient.
